Literature DB >> 25384733

The expansion of GPCR transactivation-dependent signalling to include serine/threonine kinase receptors represents a new cell signalling frontier.

Danielle Kamato1, Muhamad Ashraf Rostam, Rebekah Bernard, Terrence J Piva, Nitin Mantri, Daniel Guidone, Wenhua Zheng, Narin Osman, Peter J Little.   

Abstract

G protein-coupled receptor (GPCR) signalling is mediated through transactivation-independent signalling pathways or the transactivation of protein tyrosine kinase receptors and the recently reported activation of the serine/threonine kinase receptors, most notably the transforming growth factor-β receptor family. Since the original observation of GPCR transactivation of protein tyrosine kinase receptors, there has been considerable work on the mechanism of transactivation and several pathways are prominent. These pathways include the "triple membrane bypass" pathway and the generation of reactive oxygen species. The recent recognition of GPCR transactivation of serine/threonine kinase receptors enormously broadens the GPCR signalling paradigm. It may be predicted that the transactivation of serine/threonine kinase receptors would have mechanistic similarities with transactivation of tyrosine kinase pathways; however, initial studies suggest that these two transactivation pathways are mechanistically distinct. Important questions are the relative importance of tyrosine and serine/threonine transactivation pathways, the contribution of transactivation to overall GPCR signalling, mechanisms of transactivation and the range of cell types in which this phenomenon occurs. The ultimate significance of transactivation-dependent signalling remains to be defined but it appears to be prominent and if so will represent a new cell signalling frontier.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25384733     DOI: 10.1007/s00018-014-1775-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  80 in total

1.  Conformational changes in the G protein Gs induced by the β2 adrenergic receptor.

Authors:  Ka Young Chung; Søren G F Rasmussen; Tong Liu; Sheng Li; Brian T DeVree; Pil Seok Chae; Diane Calinski; Brian K Kobilka; Virgil L Woods; Roger K Sunahara
Journal:  Nature       Date:  2011-09-28       Impact factor: 49.962

Review 2.  Cell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle.

Authors:  Hossein B Rezaei; Danielle Kamato; Ghazaleh Ansari; Narin Osman; Peter J Little
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-08       Impact factor: 2.557

3.  Endothelin-1 stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by endothelin receptor transactivation of the transforming growth factor-[beta] type I receptor.

Authors:  Peter J Little; Micah L Burch; Robel Getachew; Sefaa Al-aryahi; Narin Osman
Journal:  J Cardiovasc Pharmacol       Date:  2010-10       Impact factor: 3.105

Review 4.  Adenyl cyclase as an adrenergic receptor.

Authors:  G A Robison; R W Butcher; E W Sutherland
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

5.  Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1.

Authors:  Raksha Jain; Philip W Shaul; Zea Borok; Brigham C Willis
Journal:  Am J Respir Cell Mol Biol       Date:  2007-03-22       Impact factor: 6.914

6.  Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor beta type I receptor.

Authors:  Micah L Burch; Mandy L Ballinger; Sundy N Y Yang; Robel Getachew; Catherine Itman; Kate Loveland; Narin Osman; Peter J Little
Journal:  J Biol Chem       Date:  2010-06-22       Impact factor: 5.157

Review 7.  EGFR transactivation in the regulation of SMC function.

Authors:  A Kalmes; G Daum; A W Clowes
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

8.  Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury.

Authors:  R Gisli Jenkins; Xiao Su; George Su; Christopher J Scotton; Eric Camerer; Geoffrey J Laurent; George E Davis; Rachel C Chambers; Michael A Matthay; Dean Sheppard
Journal:  J Clin Invest       Date:  2006-05-18       Impact factor: 14.808

9.  Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, alphavbeta3-integrin, and TGF-beta1 in response to ANG II and high glucose.

Authors:  Souad Belmadani; Mourad Zerfaoui; Hamid A Boulares; Desiree I Palen; Khalid Matrougui
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

10.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors.

Authors:  H Daub; F U Weiss; C Wallasch; A Ullrich
Journal:  Nature       Date:  1996-02-08       Impact factor: 49.962

View more
  11 in total

Review 1.  G Protein Coupled Receptor-mediated Transactivation of Extracellular Proteases.

Authors:  Allison E Schafer; Burns C Blaxall
Journal:  J Cardiovasc Pharmacol       Date:  2017-07       Impact factor: 3.105

Review 2.  Gaq proteins: molecular pharmacology and therapeutic potential.

Authors:  Danielle Kamato; Partha Mitra; Felicity Davis; Narin Osman; Rebecca Chaplin; Peter J Cabot; Rizwana Afroz; Walter Thomas; Wenhua Zheng; Harveen Kaur; Margaret Brimble; Peter J Little
Journal:  Cell Mol Life Sci       Date:  2016-11-04       Impact factor: 9.261

Review 3.  Integrating the GPCR transactivation-dependent and biased signalling paradigms in the context of PAR1 signalling.

Authors:  P J Little; M D Hollenberg; D Kamato; W Thomas; J Chen; T Wang; W Zheng; N Osman
Journal:  Br J Pharmacol       Date:  2016-02-16       Impact factor: 8.739

Review 4.  Insights into cellular signalling by G protein coupled receptor transactivation of cell surface protein kinase receptors.

Authors:  Rebecca Chaplin; Lyna Thach; Morley D Hollenberg; Yingnan Cao; Peter J Little; Danielle Kamato
Journal:  J Cell Commun Signal       Date:  2017-02-06       Impact factor: 5.782

5.  GPR124 regulates microtubule assembly, mitotic progression, and glioblastoma cell proliferation.

Authors:  Allison E Cherry; Juan Jesus Vicente; Cong Xu; Richard S Morrison; Shao-En Ong; Linda Wordeman; Nephi Stella
Journal:  Glia       Date:  2019-05-06       Impact factor: 7.452

6.  Mechanisms of PAR-1 mediated kinase receptor transactivation: Smad linker region phosphorylation.

Authors:  Danielle Kamato; Hang Ta; Rizwana Afroz; Suowen Xu; Narin Osman; Peter J Little
Journal:  J Cell Commun Signal       Date:  2019-07-09       Impact factor: 5.908

7.  EGF Receptor Transactivation by Endothelin-1 Increased CHSY-1 Mediated by NADPH Oxidase and Phosphorylation of ERK1/2.

Authors:  Hossein Babaahmadi-Rezaei; Alireza Kheirollah; Mojtaba Rashidi; Faezeh Seif; Zahra Niknam; Masoumeh Zamanpour
Journal:  Cell J       Date:  2021-10-30       Impact factor: 2.479

Review 8.  Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11.

Authors:  Danielle Kamato; Lyna Thach; Rebekah Bernard; Vincent Chan; Wenhua Zheng; Harveen Kaur; Margaret Brimble; Narin Osman; Peter J Little
Journal:  Front Cardiovasc Med       Date:  2015-03-24

Review 9.  Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research.

Authors:  Zhixiang Wang
Journal:  Int J Mol Sci       Date:  2016-01-12       Impact factor: 5.923

Review 10.  GPCR transactivation signalling in vascular smooth muscle cells: role of NADPH oxidases and reactive oxygen species.

Authors:  Raafat Mohamed; Reearna Janke; Wanru Guo; Yingnan Cao; Ying Zhou; Wenhua Zheng; Hossein Babaahmadi-Rezaei; Suowen Xu; Danielle Kamato; Peter J Little
Journal:  Vasc Biol       Date:  2019-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.